ICOS ligand costimulation is required for T-cell encephalitogenicity

被引:69
|
作者
Sporici, RA
Beswick, RL
von Allmen, C
Rumbley, CA
Hayden-Ledbetter, M
Ledbetter, JA
Perrin, PJ
机构
[1] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Sect, Philadelphia, PA 19104 USA
[2] Pacific NW Res Inst, Seattle, WA 98122 USA
关键词
EAE/MS; costimulatory molecules; T-lymphocytes; immunotherapy;
D O I
10.1006/clim.2001.5074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interaction of ICOS with its ligand on APC provides a costimulatory signal to previously activated T-cells. In these studies, we blocked the ICOS:ICOS ligand interaction with ICOS-Ig during the in vitro activation of AMP-reactive transgenic CD4(+) T-cells. The presence of ICOS-Ig in these cultures inhibited the ability of the transgenic T-cells to transfer EAE, although they entered the brains of the recipient mice. ICOS-Ig increased apoptosis in the transgenic T-cells, especially in the memory population. This enhanced apoptosis was accompanied by an increase in the BAX/BCL-2 mRNA ratio. ICOS-Ig did not prevent IL2 production, demonstrating that IL-2 production is ICOS ligand independent. IFN-gamma and IL-10 production by the transgenic T-cells, however, was suppressed. Finally, ICOS-Ig injection into mice after the first signs of EAE ameliorated clinical disease. Therefore, ICOS-Ig provides a signal distinct from CD28 costimulation that is required for the activation and viability of encephalitogenic T-cells. (C) 2001 Academic Press.
引用
收藏
页码:277 / 288
页数:12
相关论文
共 50 条
  • [31] CD20+ T-CELL LYMPHOMA - NEOPLASTIC TRANSFORMATION OF A NORMAL T-CELL SUBSET
    QUINTANILLAMARTINEZ, L
    PREFFER, F
    RUBIN, D
    FERRY, JA
    HARRIS, NL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (04) : 483 - 489
  • [32] Optimization of culture media for ex vivo T-cell expansion for adoptive T-cell therapy
    Rahimmanesh, Ilnaz
    Tavangar, Mehrsa
    Zahedi, Seyedeh Noushin
    Azizi, Yadollah
    Khanahmad Shahreza, Hossein
    ADVANCED BIOMEDICAL RESEARCH, 2022, 11 (01): : 94
  • [33] T-cell count and T-cell telomere length in patients with severe COVID-19
    Kraft, Bryan D.
    Verhulst, Simon
    Lai, Tsung-Po
    Sullenger, Bruce A.
    Wang, Yunfei
    Rountree, Wes
    Chen, Lingye
    Woods, Christopher W.
    Denny, Thomas N.
    Aviv, Abraham
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function
    Wang, Huaishan
    Chen, Hui
    Liu, Shujing
    Zhang, Jie
    Lu, Hezhe
    Somasundaram, Rajasekharan
    Choi, Robin
    Zhang, Gao
    Ou, Lingling
    Scholler, John
    Tian, Shifu
    Dong, Liyun
    Yeye, Guo
    Huang, Lili
    Connelly, Thomas
    Li, Ling
    Huang, Alexander
    Mitchell, Tara C.
    Fan, Yi
    June, Carl H.
    Mills, Gordon B.
    Guo, Wei
    Herlyn, Meenhard
    Xu, Xiaowei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
  • [35] Receptor Research Prize 2006 Lecture - The T-cell antigen receptor: A logical response to an unknown ligand
    Palmer, Ed
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2006, 26 (5-6) : 367 - 378
  • [36] Adoptive Cell Therapy for T-Cell Malignancies
    Fang, Karen Kai-Lin
    Lee, Jong Bok
    Zhang, Li
    CANCERS, 2023, 15 (01)
  • [37] T-Cell Receptor Gene-Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy
    Leisegang, Matthias
    Turqueti-Neves, Adriana
    Engels, Boris
    Blankenstein, Thomas
    Schendel, Dolores J.
    Uckert, Wolfgang
    Noessner, Elfriede
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2333 - 2343
  • [38] CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
    Bos, Rinke
    Sherman, Linda A.
    CANCER RESEARCH, 2010, 70 (21) : 8368 - 8377
  • [39] T cells activated in vitro as immunotherapy for renal, cell carcinoma: Characterization of 2 effector T-cell populations
    Garlie, NK
    Siebenlist, RE
    Lefever, AV
    JOURNAL OF UROLOGY, 2001, 166 (01): : 299 - 303
  • [40] Approaches to studying costimulation of human antiviral T cell responsesProspects for immunotherapeutic vaccines
    Lena Serghides
    Mariana Vidric
    Tania H. Watts
    Immunologic Research, 2006, 35 : 137 - 150